𝐏𝐬𝐲𝐏𝐚𝐥 𝐢𝐬 𝐧𝐨𝐰 𝐫𝐞𝐜𝐫𝐮𝐢𝐭𝐢𝐧𝐠 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐩𝐫𝐨𝐣𝐞𝐜𝐭 𝐧𝐨𝐰 𝐚𝐜𝐫𝐨𝐬𝐬 𝐟𝐨𝐮𝐫 𝐜𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬. We are exploring whether psilocybin therapy can address unmet psychological needs in individuals with the following conditions:

We are so grateful for the progress made this year in PsyPal. From our team to yours - every success for 2026 and beyond! Stay tuned in the new year for more exciting project updates!

Interested in advancements across Europe for psychedelic-assisted therapies? Prof Albino Oliveira-Maia outlined the current standing of Portugal in an article from earlier this year, highlighting the ongoing need for research & multidisciplinary collaboration: sicnoticias.pt/saude-e-bem-...

We’re proud to be representing the PsyPal project @psypaleu.bsky.social at Psychedelic Science, in Denver, and at the European Academy of Neurology Congress, in Helsinki!

🧠 One week until #EAN2025 in Helsinki! We'll be there 21–24 June with a booth in the Neurohood + a session at the Scientific Theatre. Come learn about the evolving frontier of psychedelic innovation in neurology, and about EU trial PsyPal (@psypaleu.bsky.social)! tinyurl.com/ean-session

PsyPal partners OPEN Foundation are running an open-access event to discuss psilocybin assisted therapy for end-of-life distress. This session is based on findings from a clinical trial in Australia and likely to be a very illuminating session! Register here: open-foundation.org/events/onlin...

@psychedelicalpha.bsky.social reported on a landmark event at Champalimaud Foundation this month, where national clinical guidelines for psychedelic therapy for Portugal were proposed as an interdisciplinary collaborative effort. psychedelicalpha.com/news/p%ce%b1...

This key event is taking place in Portugal next week. Watch this space- emerging from this may be a new roadmap for future national collaborations across Europe for developing multidisciplinary recommendations for clinical psychedelic use. @champalimaudf.bsky.social #PsychedelicSciSky

1/ A systematic review and network meta-analysis recently evaluated psilocybin's effectiveness in reducing depressive and anxiety symptoms among cancer patients.

Spiritual care is an integral part of PsyPal, with key work being done by Hanneke Muthert of University of Groningen. Addressing spiritual needs is considered a core tenet of palliative care - yet these needs are often underserved in practice (Quinn & Connolly, 2023).

Earlier this month, PAREA contributed to a @psypaleu.bsky.social workshop organised by @iese.bsky.social in Barcelona. The event gathered stakeholders to explore how psychedelics can be integrated into palliative care, within and beyond the PsyPal project.

Designing the Future of Psychedelic Therapy in Palliative Care - on April 3–4, @iese.bsky.social hosted a groundbreaking Design Thinking Workshop led by the PsyPal core team, convening experts from across healthcare, policy, academia, & patient advocacy. #ClinicalTrials #PolicyInnovation #PsyPal

Delighted to feature at the European Psychiatric Association Congress last week in Madrid, hosting over 5000. PsyPal formed part of the presidential symposium to discuss psychedelic treatments in psychiatry. A wonderful opportunity to meet leading figures in psychiatry across Europe! #EPA2025

Our partners, European Psychiatric Association, published this policy paper on psychedelic treatments in psychiatry. This paper highlights specific challenges, potential benefits, & practical recommendations for clinical and research use of psychedelic treatmentsl: www.cambridge.org/core/service...

A great resource to stay up to date with researchers in the field of psychedelics!

"Treating mental illness with psychedelics?" This article by Ana Luísa Monteiro of SIC Notícias outlines the current status of psychedelic clinical trials in Portugal and speaks to PsyPal partner, Albino Oliveira-Maia on the need for more research: amp.sicnoticias.pt/saude-e-bem-...

news.ki.se/a-european-perspective-on-psychedelics-research-from-pharmacology-to-clinical-effects The Karolinska Institut will be running a series of webinars on psychedelic research in Europe, which may be of interest to our followers and supporters. @karolinskainst.bsky.social #euresearch

As well as bringing you project updates, we also share relevant literature and content around psychedelic science & palliative care interests!

As well as bringing you project updates, we also share relevant literature and content around psychedelic science & palliative care interests! #psilocybintherapy #palliativecare #psychedelic

PsyPal is the first ever European grant to fund clinical research into #psychedelic-assisted therapy. Learn more about our project by visiting our website: palliativeprojects.eu/psypal/ or connect with us on LinkedIn! www.linkedin.com/company/psyp...

At PsyPal (Psilocybin Therapy for Psychological Distress in Palliative Care Patients), we're excited to join @bsky.app and to connect with individuals interested in #psychedelics & #palliativecare. Follow along to get our project updates!